loperamide has been researched along with Bacterial Infections, Gram-Negative in 2 studies
Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lubeluzole, a neuroprotective anti-ischemic drug, was tested for its ability to act as both antibiotic chemosensitizing and antipropulsive agent for the treatment of infectious diarrhea." | 8.02 | Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies. ( Budriesi, R; Caputo, L; Cavalluzzi, MM; Corazza, I; De Salvia, MA; Franchini, C; Gualdani, R; Lentini, G; Micucci, M; Milani, G; Piarulli, M; Quintieri, L; Rosato, A; Viale, M, 2021) |
| " coli, the median duration of diarrhea was 19 hours (25th to 75th percentiles, 6 to 42 hours) for those receiving loperamide plus ciprofloxacin compared with 42 hours (21 to 46 hours) for those receiving ciprofloxacin alone (P = 0." | 5.07 | Ciprofloxacin and loperamide in the treatment of bacillary dysentery. ( Bodhidatta, L; Echeverria, P; Hoge, CW; Imlarp, S; Murphy, GS; Tamura, K; Tansuphaswadikul, S, 1993) |
| "Lubeluzole, a neuroprotective anti-ischemic drug, was tested for its ability to act as both antibiotic chemosensitizing and antipropulsive agent for the treatment of infectious diarrhea." | 4.02 | Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies. ( Budriesi, R; Caputo, L; Cavalluzzi, MM; Corazza, I; De Salvia, MA; Franchini, C; Gualdani, R; Lentini, G; Micucci, M; Milani, G; Piarulli, M; Quintieri, L; Rosato, A; Viale, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalluzzi, MM | 1 |
| Budriesi, R | 1 |
| De Salvia, MA | 1 |
| Quintieri, L | 1 |
| Piarulli, M | 1 |
| Milani, G | 1 |
| Gualdani, R | 1 |
| Micucci, M | 1 |
| Corazza, I | 1 |
| Rosato, A | 1 |
| Viale, M | 1 |
| Caputo, L | 1 |
| Franchini, C | 1 |
| Lentini, G | 1 |
| Murphy, GS | 1 |
| Bodhidatta, L | 1 |
| Echeverria, P | 1 |
| Tansuphaswadikul, S | 1 |
| Hoge, CW | 1 |
| Imlarp, S | 1 |
| Tamura, K | 1 |
1 trial available for loperamide and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Ciprofloxacin and loperamide in the treatment of bacillary dysentery.
Topics: Adult; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary | 1993 |
1 other study available for loperamide and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies.
Topics: Animals; Anti-Bacterial Agents; Antidiarrheals; Bacteria; Colon; Diarrhea; Dose-Response Relationshi | 2021 |